ASXL1 and chronic myelomonocytic leukemia: The results confirmed that in MDS and CMML, but not in CNL, SETBP1 mutations are strongly associated with a poorer survival, and that the prognostic impact of SETBP1 mutations is similar to that of ASXL1 mutations [106].